Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARESS Study
2025-522812-18-00Phase 4Authorised
- Sponsor
- Hospital Clínico San Carlos
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cabergoline in endometriosis (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoints: Reduction in size of endometriotic lesions and Relief of pelvic pain. Planned start Sep 2025; status: authorised.
02
Drugs
cabergoline
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2025-522812-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522812-18-00.